Big Tech’s recent expansions into medical imaging have business watchers scrambling to decipher the unspoken stratagems beneath the conspicuous moves.

The Impella RP System is still associated with significant benefits, the FDA said, but there are certain high-risk patients who should no longer be eligible for treatment.

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, offers an overview of the trends, hot topics, research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

More than half of surveyed radiologists worry about MRI contrast availability, yet almost all—99%—wish for contrast agents that would cut current gadolinium concentrations at least in half.

Integra LifeSciences Holding Corporation, a global medical technology company, has agreed to acquire Surgical Innovation Associates (SIA), which is known as the manufacturer of monofilament mesh for plastic and reconstructive surgery. The deal is valued up to $140 million.

A randomized study of more than 450 patients with persistent atrial fibrillation is now underway. All patients have been treated, and their outcomes will be tracked for 12 months. 

MetroHealth has named Airica Steed, EdD, MBA, RN, as its next CEO and president, effective Jan. 1, 2023.

Cleveland Clinic has reported huge losses for the first three quarters of 2022, and the health system’s financial woes underscore the dire financial realities across the industry.